Skip to content

Insider · CIK 0001698554

LEE BRIAN J

officer

Files at GS (GOLDMAN SACHS GROUP INC). First filing Oct 18, 2024, latest Oct 18, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $2.1M sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
50ModeratesellGS
GOLDMAN SACHS GROUP INC
$2.1M4,000-33%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 17, 2024GS
GOLDMAN SACHS GROUP INC
SOpen-market sale
Common Stock, par value $0.01 per share
-699$529.59$370k11,396Oct 18, 2024
Oct 17, 2024GS
GOLDMAN SACHS GROUP INC
SOpen-market sale
Common Stock, par value $0.01 per share
-491$530.66$261k10,905Oct 18, 2024
Oct 17, 2024GS
GOLDMAN SACHS GROUP INC
SOpen-market sale
Common Stock, par value $0.01 per share
-410$531.90$218k10,495Oct 18, 2024
Oct 17, 2024GS
GOLDMAN SACHS GROUP INC
SOpen-market sale
Common Stock, par value $0.01 per share
-400$532.46$213k10,095Oct 18, 2024
Oct 17, 2024GS
GOLDMAN SACHS GROUP INC
SOpen-market sale
Common Stock, par value $0.01 per shareindirect: See footnote
-700$529.60$371k12,108Oct 18, 2024
Oct 17, 2024GS
GOLDMAN SACHS GROUP INC
SOpen-market sale
Common Stock, par value $0.01 per shareindirect: See footnote
-400$530.72$212k11,708Oct 18, 2024
Oct 17, 2024GS
GOLDMAN SACHS GROUP INC
SOpen-market sale
Common Stock, par value $0.01 per shareindirect: See footnote
-502$531.72$267k11,206Oct 18, 2024
Oct 17, 2024GS
GOLDMAN SACHS GROUP INC
SOpen-market sale
Common Stock, par value $0.01 per shareindirect: See footnote
-398$532.73$212k10,808Oct 18, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.